Interaction analyses showed no significant interactions between serum insulin levels and the subgroup variables in relation to NAFLD (all P for interaction > .05), suggesting that the association was robust across different population subgroups (Fig. 3). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.